GSTM1 and rheumatic disorder: However, the possible influence of GSTM1 gene deletion polymorphism on bDMARD efficacy in JIA patients opens new horizons in investigations of GST gene polymorphisms and their influence on treatment outcomes in JIA and other rheumatic diseases.